Initial Offer. In the event that Alliance wishes to conduct Development activities for any improvements to a Product, new indications for the Product or with respect to back-up and/or replacement products related to the Field (collectively, a "POTENTIAL NEW INDICATION"), Alliance shall make a written proposal to Schering setting forth in reasonable detail the scope of the Development activities proposed by Alliance, together with all material data available to Alliance relating thereto. Such presentation shall be accompanied by a draft development plan and development budget. Schering shall have the right with respect to each such proposal, exercisable upon delivery of written notice to Alliance not later than ninety (90) days following the date that such Potential New Indication is presented to Schering, to include such Potential New Indication as an Additional Indication hereunder. With respect to each such Additional Indication as to which Schering makes such election, it shall pay to Alliance ** as contained in the Development Plan approved by the JDC.
Appears in 2 contracts
Sources: License Agreement (Alliance Pharmaceutical Corp), License Agreement (Alliance Pharmaceutical Corp)